AB
Aniket Bhalchandra Kulkarni
About Aniket Bhalchandra Kulkarni
Data last updated:
Aniket Bhalchandra Kulkarni is a Director at Alfa Biomed India Private Limited (since 2024), Director at Generic Healthcare Private Limited (since 2024) and Director at Adna Foundation (since 2024), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Paper. The 3 current companies with reported revenue have a combined latest revenue of ₹135 Cr; the largest is Alfa Biomed India Private Limited at ₹117 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alfa Biomed India Private Limited U74999PN2016FTC158316 | Director | 23 Dec 2024 | 2016 | ₹117 Cr (FY 2024) | Active |
 Generic Healthcare Private Limited U33110PN2010PTC136997 | Director | 23 Dec 2024 | 2010 | ₹17.92 Cr (FY 2025) | Active |
| Adna Foundation U85300PN2021NPL202345 | Director | 23 Dec 2024 | 2021 | ₹13,210 (FY 2025) | Active |
| Sanzio Lifesciences Private Limited U21001PN2026PTC256779 | Additional Director | 23 Jun 2026 | 2026 | Active | |
| Adna Lifesciences Private Limited U21001PN2023FTC222697 | Director | 23 Dec 2024 | 2023 | Active |
Board colleagues of Aniket Bhalchandra Kulkarni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anushka Abhijit Bora | 10258161 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 2 more | Director |
| Dinesh Chandak | 09288419 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 2 more | Director |
| Kiran Sukhdeo Malekar | 09021266 | Alfa Biomed India Private Limited | Director |
| Krishna Abhijit Bora | 10830754 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 3 more | Director |
| Rohit Balkrishna Kulkarni | Alfa Biomed India Private Limited | Company Secretary | |
| Sahadot Ali Mir | 11206866 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 1 more | Director |
| Sakti Pada Chakraborty | 00064434 | Sanzio Lifesciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aniket Bhalchandra Kulkarni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aniket Bhalchandra Kulkarni
Aniket Bhalchandra Kulkarni currently holds 5 directorships: Alfa Biomed India Private Limited (Director, since 23 Dec 2024, revenue ₹117 Cr (FY 2024)); Generic Healthcare Private Limited (Director, since 23 Dec 2024, revenue ₹17.92 Cr (FY 2025)); Adna Foundation (Director, since 23 Dec 2024, revenue ₹13,210 (FY 2025)); Sanzio Lifesciences Private Limited (Additional Director, since 23 Jun 2026); Adna Lifesciences Private Limited (Director, since 23 Dec 2024).
Aniket Bhalchandra Kulkarni was first appointed on 23 Dec 2024 as Director at Alfa Biomed India Private Limited. The most recent appointment on record is 23 Jun 2026 at Sanzio Lifesciences Private Limited.
The 3 current companies of Aniket Bhalchandra Kulkarni that report revenue have a combined latest revenue of ₹135 Cr: Alfa Biomed India Private Limited ₹117 Cr (FY 2024); Generic Healthcare Private Limited ₹17.92 Cr (FY 2025); Adna Foundation ₹13,210 (FY 2025).
The current boards of Aniket Bhalchandra Kulkarni's companies include Anushka Abhijit Bora (Alfa Biomed India Private Limited), Dinesh Chandak (Alfa Biomed India Private Limited), Kiran Sukhdeo Malekar (Alfa Biomed India Private Limited), Krishna Abhijit Bora (Alfa Biomed India Private Limited), Rohit Balkrishna Kulkarni (Alfa Biomed India Private Limited), Sahadot Ali Mir (Alfa Biomed India Private Limited), among others.